Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$7.41
+1.37%
Mkt Cap $494.23M
Analyst Ratings
Buy
7
Hold
2
Sell
0
Price Target (40 analysts)
$14.17
Range $10.00 – $20.00
Implied Upside
+91.2%
Consensus $14.17 vs current $7.41
NASDAQ·Healthcare·Biotechnology
$7.41
+1.37%
Mkt Cap $494.23M
Buy
7
Hold
2
Sell
0
Price Target (40 analysts)
$14.17
Range $10.00 – $20.00
+91.2%
Consensus $14.17 vs current $7.41